AI assistant
Cigna Group — Director's Dealing 2021
Mar 3, 2021
29918_dirs_2021-03-02_943b7bd4-6969-4cc7-922d-a984e8cd788c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2021-02-26
Reporting Person: Miller Steven B (EVP, Chief Clinical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-26 | Common Stock, $.01 Par Value | A | 3831.0000 | $0.0000 | Acquired | 31377.0000 | Direct |
| 2021-02-26 | Common Stock, $.01 Par Value | F | 383.0000 | $210.3100 | Disposed | 30994.0000 | Direct |
| 2021-02-26 | Common Stock, $.01 Par Value | F | 840.0000 | $209.9000 | Disposed | 30154.0000 | Direct |
| 2021-02-26 | Common Stock, $.01 Par Value | F | 1715.0000 | $210.3100 | Disposed | 28439.0000 | Direct |
Footnotes
F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F3: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.
F4: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.